Whitney Meier’s practice focuses on complex patent litigation and contested proceedings before the United States Patent Office with an emphasis in pharmaceuticals and biotechnology. Her litigation and counseling experience cover a range of technologies, including chemotherapies, bisphosphonates, antipsychotics, small molecule formulation, genetically modified mice, and antibody manufacturing. Whitney's practice also includes many aspects of trademark law, including clearing and prosecuting U.S. and foreign trademarks.
While in law school, Whitney served as the Trade Editor for the Georgetown Journal of International Law and a student intern for the Honorable Francisco A. Besosa, United States District Court, District of Puerto Rico.
Eli Lilly & Company and ImClone Systems LLC v. Genetech, Inc. and City of Hope
Achieved favorable settlement for Eli Lilly and ImClone in case regarding the Cabilly biotechnology patents and Erbitux®, a therapy for colorectal and head and neck cancer.